Added to YB: 2026-10-06
Pitch date: 2026-09-30
096530.KQ [bullish]
Seegene, Inc.
+3.3%
current return
Author Info
No bio for this author
Company Info
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products.
Market Cap
KRW 1.7T
Pitch Price
KRW 34.8K
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.45
P/E
18.47
EV/Sales
2.41
Sector
Biotechnology
Category
dividend
Korea Quality Re-Rating Watch Sep 30: Seegene, Inc.
096530.KQ (monitor): Seegene’s molecular-diagnostics case combines a sharp earnings recovery with institutional accumulation and a potential dividend-led re-rating: operating profit rose 309.7% YoY, margin expanded 11.3pp, and foreign and qualified-institutional buyers purchased a net KRW11.69B over five days. The interim dividend signals confidence in cash generation, but 7.1% short interest and 22.4% foreign ownership could create an overhang if conviction fades; dividend sustainability and whether buying is benchmark- or thesis-driven remain unresolved.
Read full article (1 min)